Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6050047 | 0.94 | TSHR (0.67) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL3505629 | 0.92 | TSHR (0.70) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL16049519 | 0.92 | TSHR (0.70) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL15057492 | 0.92 | TSHR (0.70) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL15624121 | 0.91 | TSHR (0.54) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL153651 | 0.89 | TSHR (0.77) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL463195 | 0.89 | TSHR (0.70) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL9428735 | 0.88 | TSHR (0.59) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL10834721 | 0.86 | TSHR (0.81) | TSHRALDH1A1LMNAGAASMN1; SMN2 | |
| SCHEMBL5392962 | 0.86 | TSHR (0.81) | TSHRALDH1A1LMNAGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4506095-A | Production of linear alkenoic acids and esters | CELANESE CORPORATION (US) | 1985-03-19 | — | — | US | claimed |
| CN-110914342-A | Linker compounds, methods of production thereof, and uses thereof | 申卡尔工程和设计学院 | 2020-03-24 | — | — | CN | disclosed |
| US-20150322079-A1 | LOW CATALYST LOADING IN METATHESIS REACTIONS | EVONIK INDUSTRIES AG (DE) | 2015-11-12 | — | — | US | disclosed |
| US-20150322079-A1 | LOW CATALYST LOADING IN METATHESIS REACTIONS | EVONIK INDUSTRIES AG (DE) | 2015-11-12 | — | — | US | disclosed |
| EP-2711351-A1 | Low catalyst loading in metathesis reactions | Evonik Industries AG (DE) | 2014-03-26 | — | — | EP | disclosed |
| US-7019068-B2 | Polymer compositions comprising telomers and articles or parts using these compositions | SOLVAY (SOCIETE ANONYME) (BE) | 2006-03-28 | — | — | US | disclosed |
| EP-1368422-B1 | POLYMER COMPOSITIONS COMPRISING TELOMERS AND ARTICLES OR PARTS USING THESE COMPOSITIONS | SOLVAY (BE) | 2005-08-24 | — | — | EP | disclosed |
| US-20040097625-A1 | Polymer compositions comprising telomers and articles or parts using these compositions | SOLVAY (SOCIETE ANONYME) (BE) | 2004-05-20 | — | — | US | disclosed |
| EP-1368422-A1 | POLYMER COMPOSITIONS COMPRISING TELOMERS AND ARTICLES OR PARTS USING THESE COMPOSITIONS | SOLVAY (SOCIETE ANONYME) (BE) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002057351-A1 | POLYMER COMPOSITIONS COMPRISING TELOMERS AND ARTICLES OR PARTS USING THESE COMPOSITIONS | Solvay (Société Anonyme) (BE) | 2002-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322079-A1 | LOW CATALYST LOADING IN METATHESIS REACTIONS | APEX1, PMS2, MAX | TSHR 4795/4885ALDH1A1 2091/4885LMNA 2185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.